Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

Fig. 1

Clustering analysis of dysregulated miRNAs in MDS patients during AZA + LEN therapy. A Venn diagram displaying the overlap among all differentially expressed miRNAs (including miRNA precursors and short RNAs not belonging to the miRNA family) at baseline (T0), the 4th (T4) and the 8th (T8) cycle of AZA + LEN therapy. Data are filtered by setting the statistical significance at p value < 0.05 and abs(logFC) > 0.5. B Venn diagram displaying the overlap among differentially expressed mature miRNAs at baseline (T0), the 4th (T4) and the 8th (T8) cycle of AZA + LEN therapy. Data are filtered by setting the statistical significance at p value < 0.05 and abs(logFC) > 0.5

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us